X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38) 38
index medicus (35) 35
female (27) 27
middle aged (23) 23
oncology (20) 20
aged (19) 19
adult (17) 17
cancer (13) 13
cervical cancer (12) 12
expression (12) 12
survival (12) 12
aged, 80 and over (11) 11
immunology (11) 11
male (11) 11
prognosis (10) 10
t cells (10) 10
tumors (10) 10
uterine cervical neoplasms - immunology (10) 10
immunohistochemistry (9) 9
research (9) 9
uterine cervical neoplasms - pathology (9) 9
immunotherapy (8) 8
pathology (8) 8
carcinoma (7) 7
genetic aspects (7) 7
human papillomavirus (7) 7
lymphocytes, tumor-infiltrating - immunology (7) 7
development and progression (6) 6
lymphocytes (6) 6
medicine & public health (6) 6
squamous-cell carcinoma (6) 6
adenocarcinoma - pathology (5) 5
animals (5) 5
cd8-positive t-lymphocytes - immunology (5) 5
flow cytometry (5) 5
gene expression (5) 5
health aspects (5) 5
histocompatibility antigens (5) 5
hla histocompatibility antigens (5) 5
macrophages (5) 5
medical prognosis (5) 5
medicine (5) 5
metastasis (5) 5
patient outcomes (5) 5
research article (5) 5
abridged index medicus (4) 4
adenocarcinoma (4) 4
adolescent (4) 4
analysis (4) 4
care and treatment (4) 4
cell line, tumor (4) 4
cervix (4) 4
down-regulation (4) 4
hpv (4) 4
human-papillomavirus (4) 4
immune response (4) 4
infections (4) 4
medical research (4) 4
medicine/public health, general (4) 4
metastases (4) 4
multidisciplinary sciences (4) 4
mutation (4) 4
neoplasm staging (4) 4
papillomavirus infections (4) 4
patients (4) 4
physiological aspects (4) 4
squamous cell carcinoma (4) 4
survival rate (4) 4
t-cells (4) 4
therapy (4) 4
tumor microenvironment (4) 4
uterine cervical neoplasms - genetics (4) 4
uterine cervical neoplasms - mortality (4) 4
uterine cervical neoplasms - virology (4) 4
adenocarcinoma - immunology (3) 3
alphapapillomavirus - genetics (3) 3
angiogenesis (3) 3
antigens (3) 3
apoptosis (3) 3
association (3) 3
biopsy (3) 3
cancer patients (3) 3
cancer research (3) 3
carcinoma, squamous cell - immunology (3) 3
carcinoma, squamous cell - pathology (3) 3
class-i (3) 3
dendritic cells (3) 3
differentiation (3) 3
disease models, animal (3) 3
disease progression (3) 3
foxp3 (3) 3
gene expression regulation, neoplastic (3) 3
hematology (3) 3
histocompatibility antigens class i - metabolism (3) 3
hla-dr antigens - genetics (3) 3
hybridization (3) 3
immune system (3) 3
kaplan-meier estimate (3) 3
loss of heterozygosity (3) 3
lymph nodes (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Immunology and Immunotherapy, ISSN 0340-7004, 2015, Volume 64, Issue 10, pp. 1241 - 1250
Targeted therapy with sunitinib, pazopanib or everolimus has improved treatment outcome for patients with metastatic renal cell carcinoma patients (RCC).... 
Sunitinib | Immunology | Medicine & Public Health | Tumor-infiltrating lymphocytes | Renal cell carcinoma | Myeloid-derived suppressor cells | Oncology | Cancer Research | Adoptive cell therapy | SURVIVAL | IMMUNOLOGY | COMBINATION | CANCER | INTERFERON-ALPHA | MELANOMA | THERAPY | ONCOLOGY | IMMUNE SUPPRESSION | IMMUNOTHERAPY | T-CELLS | MODULATION | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Molecular Targeted Therapy | Carcinoma, Renal Cell - immunology | Indoles - administration & dosage | T-Lymphocytes - transplantation | Neoplasm Metastasis | Interleukin-2 - administration & dosage | Myeloid Cells - immunology | Pyrroles - administration & dosage | Immunotherapy | Pyrroles - adverse effects | Adult | Female | Myeloid Cells - drug effects | Everolimus | Kidney Neoplasms - therapy | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Pyrimidines - administration & dosage | Programmed Cell Death 1 Receptor - metabolism | Treatment Outcome | Combined Modality Therapy | Lymphocytes, Tumor-Infiltrating - drug effects | Sirolimus - administration & dosage | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - adverse effects | Carcinoma, Renal Cell - therapy | Cell Line, Tumor | Sulfonamides - adverse effects | T-Lymphocytes - immunology | Aged | Cell Proliferation - drug effects | Sulfonamides - administration & dosage | Lymphocytes, Tumor-Infiltrating - immunology | Antimitotic agents | Carcinoma, Renal cell | T cells | Antineoplastic agents
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2015, Volume 10, Issue 7, p. e0133670
Introduction Squamous cell carcinoma (SCC), adenocarcinoma (AC), and adenosquamous carcinoma (ASC) are the most common histological subtypes of cervical... 
GENE-MUTATIONS | LUNG-CANCER | PI3K | WNT/BETA-CATENIN | PATHWAY | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | SQUAMOUS-CELL CARCINOMA | INHIBITORS | BETA-CATENIN | BREAST | Adenocarcinoma - pathology | Prognosis | Cytoskeletal Proteins - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Adenocarcinoma - classification | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Uterine Cervical Neoplasms - pathology | Uterine Cervical Neoplasms - genetics | Phosphatidylinositol 3-Kinases - genetics | Neoplasm Metastasis | Class I Phosphatidylinositol 3-Kinases | CARD Signaling Adaptor Proteins | Carcinoma, Squamous Cell - classification | Adult | Female | Adenocarcinoma - genetics | Mutation | Uterine Cervical Neoplasms - classification | Medicine, Experimental | Medical research | Development and progression | Genetic aspects | Mass spectrometry | Cervical cancer | Adenocarcinoma | Profiling | Genes | Infections | Metastasis | Multivariate analysis | Lymph nodes | K-Ras protein | Metastases | Ethics | Human papillomavirus | Classification | Cervical carcinoma | Squamous cell carcinoma | Hot spots | Gynecology | Mass spectroscopy | Radiation therapy | Cervix | Survival | Patients | Obstetrics | Pathology | Womens health | Medical prognosis | Morphology | Infiltration | Adenosquamous | Tumors | Cancer
Journal Article
Cell, ISSN 0092-8674, 2003, Volume 115, Issue 5, pp. 523 - 535
Journal Article